This inventor holds 1 USPTO granted patent. Top assignee: Brigham Young University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Christopher Mendoza: Innovator in Metastasis Inhibition
Introduction
Christopher Mendoza is a notable inventor based in Provo, UT (US). He has made significant contributions to the field of cancer research, particularly in the area of metastasis inhibition. His work is vital for developing new therapeutic strategies to combat cancer.
Latest Patents
Mendoza holds a patent for a "Metastasis Inhibiting Protein." This innovation represents a crucial step forward in understanding and potentially controlling the spread of cancer cells in the body. The patent showcases his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Christopher Mendoza is affiliated with Brigham Young University, where he conducts research and collaborates with other experts in the field. His academic background and research focus have positioned him as a key player in cancer research.
Collaborations
Mendoza works alongside Dario Mizrachi, contributing to a collaborative environment that fosters innovation and discovery. Their partnership exemplifies the importance of teamwork in scientific research.
Conclusion
Christopher Mendoza's work in developing a metastasis inhibiting protein highlights his dedication to advancing cancer research. His contributions are essential for paving the way toward new treatments and improving the lives of those affected by cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile